MAVIK Side Effects

7021146-8 | Supraventricular Tachyarrhythmia
on Sep 28, 2010 Male patient from CANADA , weighting 203.9 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient experienced the following unwanted or unexpected effects: supraventricular tachyarrhythmia. Mavik dosage: . Patient was hospitalized.

7016269-3 | Supraventricular Tachycardia
Patient was taking Mavik (View Usage). Patient had the following side effects: supraventricular tachycardia on Sep 17, 2010 from CANADA Additional patient health information: Male patient , weighting 203.9 lb, was diagnosed with essential hypertension and. Mavik dosage: . Patient was hospitalized.

6974182-1 | Syncope
Adverse event was reported on Aug 30, 2010 by a Male patient taking Mavik (View Usage) (Dosage: Daily Dose: 4mg) was diagnosed with essential hypertension and. Location: CANADA , weighting 205.0 lb, After Mavik was administered, patient had the following side effects: syncope. During the same period patient was treated with BISOPROLOL (Daily Dose: 5gm) (View Bisoprolol Review and Bisoprolol Label ), LASIX (Daily Dose: 40gm) (View Lasix Review and Lasix Label ).

6974144-4 | Fall, Fracture Displacement, Mobility Decreased, Multiple Sclerosis
on Sep 02, 2010 Female patient from CANADA , weighting 136.2 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), fracture displacement, mobility decreased, multiple sclerosis (What is multiple sclerosis?). Mavik dosage: 2 Mg Daily.


6959215-0 | Ill-defined Disorder, Mobility Decreased, Multiple Sclerosis
on Aug 25, 2010 Female patient from CANADA , weighting 136.2 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient had the following side effects: ill-defined disorder, mobility decreased, multiple sclerosis (What is multiple sclerosis?). Mavik dosage: 2 Mg Daily.

6946122-2 | Coronary Artery Occlusion
Patient was taking Mavik (View Usage). After Mavik was administered, patient had the following side effects: coronary artery occlusion on Aug 19, 2010 from CANADA Additional patient health information: Male patient , weighting 205.0 lb, was diagnosed with essential hypertension and. Mavik dosage: Daily Dose: 4mg. During the same period patient was treated with BISOPROLOL (Daily Dose: 5gm) (View Bisoprolol Review and Bisoprolol Label ), LASIX (Daily Dose: 40gm) (View Lasix Review and Lasix Label ).

6933083-5 | Infarction
Adverse event was reported on Aug 12, 2010 by a Male patient taking Mavik (View Usage) (Dosage: ) was diagnosed with essential hypertension and. Location: CANADA , weighting 172.4 lb, Patient experienced the following unwanted or unexpected effects: infarction. During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ).

6933057-4 | Atrial Fibrillation
on Aug 11, 2010 Male patient from CANADA , weighting 180.8 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Mavik dosage: . During the same period patient was treated with SOTACOR (View Sotacor Review and Sotacor Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), PROPAFENONE HCL (View Propafenone Hcl Review and Propafenone Hcl Label ).

6930253-7 | Acute Coronary Syndrome, Coronary Artery Stenosis, Eye Haemorrhage, Myocardial Infarction, Ocular Vascular Disorder, Visual Acuity Reduced
on Aug 04, 2010 Male patient from CANADA , weighting 194.0 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). After Mavik was administered, patient had the following side effects: acute coronary syndrome, coronary artery stenosis, eye haemorrhage, myocardial infarction, ocular vascular disorder, visual acuity reduced. Mavik dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), PLAVIX (View Plavix Review and Plavix Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), CELEBREX (View Celebrex Review and Celebrex Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), CRESTOR (View Crestor Review and Crestor Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6926313-7 | Fall, Hip Fracture
Patient was taking Mavik (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), hip fracture on Aug 06, 2010 from CANADA Additional patient health information: Female patient , weighting 125.7 lb, was diagnosed with essential hypertension and. Mavik dosage: 1mg Daily. Patient was hospitalized.

6911630-7 | Fall, Hip Fracture
Adverse event was reported on Jul 28, 2010 by a Female patient taking Mavik (View Usage) (Dosage: 1mg Daily) was diagnosed with essential hypertension and. Location: CANADA , weighting 125.7 lb, Patient had the following side effects: fall (What is fall?), hip fracture. Patient was hospitalized.

6909657-4 | Infarction
on Jul 29, 2010 Female patient from CANADA , weighting 178.6 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). After Mavik was administered, patient had the following side effects: infarction. Mavik dosage: 1mg Qd. During the same period patient was treated with HYDROCHLOROTHIAZIDE (12.5mg Daily Also Used Post Infarctus) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6899795-7 | Arterial Occlusive Disease
on Jul 26, 2010 Male patient from CANADA , weighting 195.1 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient experienced the following unwanted or unexpected effects: arterial occlusive disease. Mavik dosage: .

6888824-2 | Atrial Fibrillation
Patient was taking Mavik (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?) on Jul 22, 2010 from CANADA Additional patient health information: Male patient , weighting 180.8 lb, was diagnosed with essential hypertension and. Mavik dosage: . During the same period patient was treated with SOTACOR (View Sotacor Review and Sotacor Label ).

6876870-4 | Hysterectomy
Adverse event was reported on Jul 22, 2010 by a Female patient taking Mavik (View Usage) (Dosage: 2 Mg Daily) was diagnosed with essential hypertension and. Location: CANADA , weighting 143.5 lb, After Mavik was administered, patient had the following side effects: hysterectomy (What is hysterectomy?). Patient was hospitalized.

6872251-8 | Hysterectomy
on Jul 15, 2010 Female patient from CANADA , weighting 143.5 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient experienced the following unwanted or unexpected effects: hysterectomy (What is hysterectomy?). Mavik dosage: 2 Mg Daily. Patient was hospitalized.

6871634-X | Acute Coronary Syndrome, Coronary Artery Stenosis, Eye Haemorrhage, Myocardial Infarction, Ocular Vascular Disorder, Visual Acuity Reduced
on Jul 13, 2010 Male patient from CANADA , weighting 194.0 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient had the following side effects: acute coronary syndrome, coronary artery stenosis, eye haemorrhage, myocardial infarction, ocular vascular disorder, visual acuity reduced. Mavik dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), PLAVIX (View Plavix Review and Plavix Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), CELEBREX (View Celebrex Review and Celebrex Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), CRESTOR (View Crestor Review and Crestor Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6871496-0 | Myocardial Infarction
Patient was taking Mavik (View Usage). After Mavik was administered, patient had the following side effects: myocardial infarction on Jul 16, 2010 from CANADA Additional patient health information: Female patient , weighting 149.9 lb, was diagnosed with blood pressure increased and. Mavik dosage: . Patient was hospitalized.

6848241-8 | Infarction
Adverse event was reported on Jul 07, 2010 by a Male patient taking Mavik (View Usage) (Dosage: ) was diagnosed with essential hypertension and. Location: CANADA , weighting 172.4 lb, Patient experienced the following unwanted or unexpected effects: infarction. During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ).

6815155-9 | Aortic Aneurysm
on Jun 25, 2010 Male patient from CANADA , weighting 165.3 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient had the following side effects: aortic aneurysm (What is aortic aneurysm?). Mavik dosage: 1mg Qd. During the same period patient was treated with AMLODIPINE (5mg Qd) (View Amlodipine Review and Amlodipine Label ).

6809680-4 | Colitis Ischaemic, Pneumonia, Renal Failure, Respiratory Failure, Sepsis
on Jun 21, 2010 Male patient from CANADA , weighting 260.1 lb, was diagnosed with hypertension and was treated with Mavik (View Usage). After Mavik was administered, patient had the following side effects: colitis ischaemic, pneumonia (What is pneumonia?), renal failure, respiratory failure, sepsis (What is sepsis?). Mavik dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), PLAVIX (View Plavix Review and Plavix Label ), NORVASC (View Norvasc Review and Norvasc Label ), SEROQUEL (At Bedtime) (View Seroquel Review and Seroquel Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

6809309-5 | Myocardial Infarction
Patient was taking Mavik (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction on Jun 25, 2010 from CANADA Additional patient health information: Male patient , weighting 194.0 lb, was diagnosed with essential hypertension and. Mavik dosage: . Patient was hospitalized.

6801758-4 | Angina Pectoris, Coronary Artery Stenosis
Adverse event was reported on Jun 19, 2010 by a Male patient taking Mavik (View Usage) (Dosage: ) was diagnosed with essential hypertension and. Location: CANADA , weighting 176.4 lb, Patient had the following side effects: angina pectoris, coronary artery stenosis. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), HYDRODIURIL (View Hydrodiuril Review and Hydrodiuril Label ).

6791008-X | Abdominal Pain, Adenocarcinoma, Ascites, Hepatic Neoplasm, Metastatic Neoplasm, Neoplasm Malignant
on Jun 15, 2010 Male patient from CANADA , weighting 167.6 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). After Mavik was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), adenocarcinoma, ascites, hepatic neoplasm, metastatic neoplasm, neoplasm malignant. Mavik dosage: 1mg Daily. During the same period patient was treated with NORVASC (5mg Daily) (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6766922-1 | Foot Fracture
on Jun 01, 2010 Male patient from CANADA , weighting 198.4 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient experienced the following unwanted or unexpected effects: foot fracture. Mavik dosage: .

6747833-4 | Transient Ischaemic Attack
Patient was taking Mavik (View Usage). Patient had the following side effects: transient ischaemic attack on May 20, 2010 from CANADA Additional patient health information: Female patient , weighting 194.0 lb, was diagnosed with essential hypertension and. Mavik dosage: 1 Mg Daily. During the same period patient was treated with MONOCOR (View Monocor Review and Monocor Label ).

6745641-1 | Abdominal Pain, Metastatic Neoplasm, Neoplasm Malignant
Adverse event was reported on May 18, 2010 by a Male patient taking Mavik (View Usage) (Dosage: 1mg Daily) was diagnosed with essential hypertension and. Location: CANADA , weighting 167.6 lb, After Mavik was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), metastatic neoplasm, neoplasm malignant. During the same period patient was treated with NORVASC (5mg Daily) (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6744985-7 | Fracture
on May 19, 2010 Male patient from CANADA , weighting 198.4 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient experienced the following unwanted or unexpected effects: fracture (What is fracture?). Mavik dosage: .

6741572-1 | Infarction
on May 17, 2010 Female patient from CANADA , weighting 178.6 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient had the following side effects: infarction. Mavik dosage: 1mg Qd.

6736675-1 | Bradycardia, Torsade De Pointes
Patient was taking Mavik (View Usage). After Mavik was administered, patient had the following side effects: bradycardia, torsade de pointes on May 12, 2010 from CANADA Additional patient health information: Female patient , weighting 215.2 lb, was diagnosed with essential hypertension and. Mavik dosage: . During the same period patient was treated with TIAZAC (View Tiazac Review and Tiazac Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

6736087-0 | Post Procedural Complication
Adverse event was reported on May 11, 2010 by a Female patient taking Mavik (View Usage) (Dosage: 2mg Daily) was diagnosed with essential hypertension and. Location: CANADA , weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: post procedural complication. Patient was hospitalized.

6736024-9 | Transient Ischaemic Attack
on May 13, 2010 Female patient from CANADA , weighting 197.3 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient had the following side effects: transient ischaemic attack. Mavik dosage: 1 Mg Daily. During the same period patient was treated with MONOCOR (View Monocor Review and Monocor Label ).

6734457-8 | Hospitalisation
on May 10, 2010 Male patient from CANADA , weighting 167.6 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). After Mavik was administered, patient had the following side effects: hospitalisation. Mavik dosage: 1mg Daily. During the same period patient was treated with NORVASC (5mg Daily) (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6732873-1 | Angioplasty
Patient was taking Mavik (View Usage). Patient experienced the following unwanted or unexpected effects: angioplasty (What is angioplasty?) on May 10, 2010 from CANADA Additional patient health information: Male patient , weighting 176.4 lb, was diagnosed with essential hypertension and. Mavik dosage: . During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

6730259-7 | Quadriplegia, Road Traffic Accident
Adverse event was reported on May 11, 2010 by a Male patient taking Mavik (View Usage) (Dosage: ) was diagnosed with essential hypertension and. Location: CANADA , weighting 217.4 lb, Patient had the following side effects: quadriplegia, road traffic accident.

6723224-7 | Acute Coronary Syndrome, Angina Pectoris, Cardiac Disorder, Carotid Artery Stenosis, Coronary Artery Disease, Myocardial Infarction, Pneumothorax, Right Ventricular Dysfunction, Ventricular Hypokinesia
on May 06, 2010 Male patient from CANADA , weighting 158.3 lb, was diagnosed with hypertension, acute myocardial infarction, chronic obstructive pulmonary disease and was treated with Mavik (View Usage). After Mavik was administered, patient had the following side effects: acute coronary syndrome, angina pectoris, cardiac disorder, carotid artery stenosis, coronary artery disease (What is coronary artery disease?), myocardial infarction, pneumothorax, right ventricular dysfunction, ventricular hypokinesia. Mavik dosage: . During the same period patient was treated with PUFFERS (View Puffers Review and Puffers Label ), BISOPROL (View Bisoprol Review and Bisoprol Label ). Patient was hospitalized.

6717103-9 | Post Procedural Complication
on Apr 30, 2010 Female patient from CANADA , weighting 176.4 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient experienced the following unwanted or unexpected effects: post procedural complication. Mavik dosage: 2mg Daily. Patient was hospitalized.

6712349-8 | Myocardial Infarction
Patient was taking Mavik (View Usage). Patient had the following side effects: myocardial infarction on Apr 29, 2010 from CANADA Additional patient health information: Male patient , weighting 176.6 lb, was diagnosed with essential hypertension and. Mavik dosage: 1 Mg Daily.

6712258-4 | Quadriplegia, Road Traffic Accident
Adverse event was reported on Apr 27, 2010 by a Male patient taking Mavik (View Usage) (Dosage: ) was diagnosed with essential hypertension and. Location: CANADA , weighting 217.4 lb, After Mavik was administered, patient had the following side effects: quadriplegia, road traffic accident.

6712210-9 | Atrial Fibrillation, Dizziness, Syncope
on Apr 26, 2010 Male patient from CANADA , weighting 205.0 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), dizziness (What is dizziness?), syncope. Mavik dosage: 2mg Daily. During the same period patient was treated with BISOPROLOL FUMARATE (5mg) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), FLOMAX (0.4 Daily) (View Flomax Review and Flomax Label ), LIPITOR (20 Daily) (View Lipitor Review and Lipitor Label ), PANTOPRAZOLE (40 Daily) (View Pantoprazole Review and Pantoprazole Label ), MONOCOR (5mg Daily) (View Monocor Review and Monocor Label ). Patient was hospitalized.

6710290-8 | Fall, Hip Fracture
on Apr 26, 2010 Female patient from CANADA , weighting 125.7 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient had the following side effects: fall (What is fall?), hip fracture. Mavik dosage: 1mg Daily. Patient was hospitalized.

6700013-0 | Hypertension
Patient was taking Mavik (View Usage). After Mavik was administered, patient had the following side effects: hypertension on Jan 26, 2010 from UNITED STATES Additional patient health information: Male patient , 53 years of age, . Mavik dosage: .

6698556-1 | Gastrooesophageal Reflux Disease, Hiatus Hernia
Adverse event was reported on Apr 19, 2010 by a Female patient taking Mavik (View Usage) (Dosage: ) . Location: CANADA , weighting 156.1 lb, Patient experienced the following unwanted or unexpected effects: gastrooesophageal reflux disease, hiatus hernia.

6698049-1 | Arterial Occlusive Disease
on Apr 19, 2010 Male patient from CANADA , weighting 195.1 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). Patient had the following side effects: arterial occlusive disease. Mavik dosage: .

6697352-9 | Atrial Fibrillation
on Apr 16, 2010 Male patient from CANADA , weighting 205.0 lb, was diagnosed with essential hypertension and was treated with Mavik (View Usage). After Mavik was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Mavik dosage: 2mg Daily. During the same period patient was treated with BISOPROLOL (5mg) (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6685260-9 | Arterial Occlusive Disease
Patient was taking Mavik (View Usage). Patient experienced the following unwanted or unexpected effects: arterial occlusive disease on Apr 08, 2010 from CANADA Additional patient health information: Male patient , weighting 195.1 lb, was diagnosed with essential hypertension and. Mavik dosage: .

6682688-8 | Acute Coronary Syndrome, Angina Pectoris, Cardiac Disorder, Carotid Artery Stenosis, Coronary Artery Disease, Myocardial Infarction, Pneumothorax, Right Ventricular Dysfunction, Ventricular Hypokinesia
Adverse event was reported on Apr 08, 2010 by a Male patient taking Mavik (View Usage) (Dosage: ) was diagnosed with hypertension, chronic obstructive pulmonary disease and. Location: CANADA , weighting 158.1 lb, Patient had the following side effects: acute coronary syndrome, angina pectoris, cardiac disorder, carotid artery stenosis, coronary artery disease (What is coronary artery disease?), myocardial infarction, pneumothorax, right ventricular dysfunction, ventricular hypokinesia. During the same period patient was treated with PUFFERS (View Puffers Review and Puffers Label ). Patient was hospitalized.

6680261-9 | Hiatus Hernia
on Apr 07, 2010 Female patient from CANADA , weighting 156.1 lb, was treated with Mavik (View Usage). After Mavik was administered, patient had the following side effects: hiatus hernia. Mavik dosage: .

6675741-6 | Adjustment Disorder
on Mar 31, 2010 Male patient from CANADA , weighting 138.9 lb, was diagnosed with hypertension, anxiety (What is anxiety?) and was treated with Mavik (View Usage). Patient experienced the following unwanted or unexpected effects: adjustment disorder. Mavik dosage: . During the same period patient was treated with ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

6675653-8 | Coronary Arterial Stent Insertion
Patient was taking Mavik (View Usage). Patient had the following side effects: coronary arterial stent insertion on Apr 01, 2010 from CANADA Additional patient health information: Male patient , weighting 195.1 lb, was diagnosed with essential hypertension and. Mavik dosage: .